semaglutide fda approved for weight loss What's New in Obesity Treatment? Live Updates on Semaglutide's Current

Behavioral Support Regular self-weighing (at least weekly) helps catch early weight regain

Mounjaros dual GIP/GLP-1 mechanism promotes more aggressive weight loss (averaging 21% in year one according to SURMOUNT-4 trial data) compared to single-mechanism GLP-1 medications like Wegovy (15%) or Saxenda (8%)

None of that is alarming at sensible doses, and the heart rate change reported in trials was minor, but it is the same receptor doing both jobs

FDA-approved versions come in branded boxes and pens Wegovy, Ozempic, Mounjaro, Zepbound, Saxenda, or the newer oral option Foundayo

Instead, they pay the average retail price, which fluctuates and varies by pharmacy and location

[DOI] [PubMed] [Google Scholar] 10.Liao C-C, Shih C-C, Yeh C-C, et al